Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Khan A, Grey A, Shoback D.

J Clin Endocrinol Metab. 2009 Feb;94(2):373-81. doi: 10.1210/jc.2008-1762. Review.

PMID:
19193912
[PubMed - indexed for MEDLINE]
2.

Cinacalcet for the treatment of primary hyperparathyroidism.

Dillon ML, Frazee LA.

Am J Ther. 2011 Jul;18(4):313-22. doi: 10.1097/MJT.0b013e3181bdc3d0. Review.

PMID:
20228675
[PubMed - indexed for MEDLINE]
3.

Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR.

J Clin Endocrinol Metab. 2009 Feb;94(2):351-65. doi: 10.1210/jc.2008-1760. Review.

PMID:
19193910
[PubMed - indexed for MEDLINE]
4.

Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.

Lewiecki EM.

J Clin Densitom. 2010 Oct-Dec;13(4):324-34. doi: 10.1016/j.jocd.2010.06.004. Review.

PMID:
21029971
[PubMed - indexed for MEDLINE]
5.

Asymptomatic primary hyperparathyroidism: surgical and medical management.

Francucci CM, Ceccoli L, Caudarella R, Rilli S, Vescini F, Boscaro M.

J Endocrinol Invest. 2011 Jul;34(7 Suppl):50-4.

PMID:
21985981
[PubMed - indexed for MEDLINE]
6.

Medical Management of Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.

Marcocci C, Bollerslev J, Khan AA, Shoback DM.

J Clin Endocrinol Metab. 2014 Aug 27:jc20141417. [Epub ahead of print]

PMID:
25162668
[PubMed - as supplied by publisher]
7.

Medical management of primary hyperparathyroidism.

Khan AA.

J Clin Densitom. 2013 Jan-Mar;16(1):60-3. doi: 10.1016/j.jocd.2012.11.010. Review.

PMID:
23374743
[PubMed - indexed for MEDLINE]
8.

Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database.

Keutgen XM, Buitrago D, Filicori F, Kundel A, Elemento O, Fahey TJ 3rd, Zarnegar R.

Ann Surg. 2012 May;255(5):981-5. doi: 10.1097/SLA.0b013e31824c5252.

PMID:
22470074
[PubMed - indexed for MEDLINE]
9.

Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism.

Faggiano A, Di Somma C, Ramundo V, Severino R, Vuolo L, Coppola A, Panico F, Savastano S, Lombardi G, Colao A, Gasperi M.

Endocrine. 2011 Jun;39(3):283-7. doi: 10.1007/s12020-011-9459-0. Epub 2011 Mar 29.

PMID:
21445714
[PubMed - indexed for MEDLINE]
10.

Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.

Peacock M, Bilezikian JP, Bolognese MA, Borofsky M, Scumpia S, Sterling LR, Cheng S, Shoback D.

J Clin Endocrinol Metab. 2011 Jan;96(1):E9-18. doi: 10.1210/jc.2010-1221. Epub 2010 Oct 13.

PMID:
20943783
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.

Del Prete M, Marotta V, Ramundo V, Marciello F, Di Sarno A, Esposito R, Carratù AC, De Luca Di Roseto C, Di Somma C, Colao A, Faggiano A.

Minerva Endocrinol. 2013 Dec;38(4):389-94.

PMID:
24285106
[PubMed - indexed for MEDLINE]
12.

Asymptomatic primary hyperparathyroidism: new issues and new questions--bridging the past with the future.

Bilezikian JP, Potts JT Jr.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N57-67. Review.

PMID:
12412779
[PubMed - indexed for MEDLINE]
13.

Primary hyperparathyroidism and the skeleton.

Mosekilde L.

Clin Endocrinol (Oxf). 2008 Jul;69(1):1-19. doi: 10.1111/j.1365-2265.2007.03162.x. Epub 2008 Jul 1. Review.

PMID:
18167138
[PubMed - indexed for MEDLINE]
14.

Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.

Duntas LH, Stathatos N.

Endocrine. 2011 Jun;39(3):199-204. doi: 10.1007/s12020-011-9452-7. Epub 2011 Mar 26. Review.

PMID:
21442382
[PubMed - indexed for MEDLINE]
15.

Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care.

Pallan S, Khan A.

Can Fam Physician. 2011 Feb;57(2):184-9.

PMID:
21321169
[PubMed - in process]
Free PMC Article
16.

[Medical treatment of primary hyperparathyroidism: role of calcimimetics].

Muñoz Torres M, García Martín A.

Endocrinol Nutr. 2009 Apr;56 Suppl 1:29-34. doi: 10.1016/S1575-0922(09)70853-8. Epub 2009 May 18. Spanish.

PMID:
19627758
[PubMed - indexed for MEDLINE]
17.

Update on the use of cinacalcet in the management of primary hyperparathyroidism.

Marcocci C, Cetani F.

J Endocrinol Invest. 2012 Jan;35(1):90-5. doi: 10.3275/8112. Epub 2011 Nov 21. Review.

PMID:
22104762
[PubMed - indexed for MEDLINE]
18.

[Medical treatment of patients with primary hyperparathyroidism].

Vestergaard P, Mosekilde L.

Ugeskr Laeger. 2009 Aug 10;171(33):2284-7. Danish.

PMID:
19732508
[PubMed - indexed for MEDLINE]
19.

[Alendronate increases bone mineral density in patients with symptomatic primary hyperparathyroidism].

Misiorowski W.

Endokrynol Pol. 2005 Nov-Dec;56(6):871-5. Polish.

PMID:
16821204
[PubMed - indexed for MEDLINE]
20.

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, Rao DS, Rubin MR, Goltzman D, Silverberg SJ, Marx SJ, Peacock M, Mosekilde L, Bouillon R, Lewiecki EM.

J Clin Endocrinol Metab. 2009 Feb;94(2):340-50. doi: 10.1210/jc.2008-1758. Review.

PMID:
19193909
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk